News - Page 186 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

Post published:April 26, 2021
Post category:Press Release

Read more about the article Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Post published:April 26, 2021
Post category:Press Release

Read more about the article Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Post published:April 26, 2021
Post category:Press Release

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Post published:April 26, 2021
Post category:Press Release

Read more about the article Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief Effort in St. Vincent and the Grenadines

Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief Effort in St. Vincent and the Grenadines

Post published:April 23, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: MindMed to List on Nasdaq; Atai IPO Unveiled; Champignon Brands Resumes Trading

Psychedelic Bulletin: MindMed to List on Nasdaq; Atai IPO Unveiled; Champignon Brands Resumes Trading

Post published:April 23, 2021
Post category:Psychedelic Bulletin

Read more about the article MindMed To Commence Trading on Nasdaq

MindMed To Commence Trading on Nasdaq

Post published:April 23, 2021
Post category:Press Release

Read more about the article Champignon Brands Announces Revocation of Cease Trade Orders

Champignon Brands Announces Revocation of Cease Trade Orders

Post published:April 22, 2021
Post category:Press Release

Read more about the article Silo Pharma (SILO) Announces Plans to Uplist to the NASDAQ

Silo Pharma (SILO) Announces Plans to Uplist to the NASDAQ

Post published:April 22, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application

Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application

Post published:April 22, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.